Drug shortage relief targeted as PAI Pharma acquires Nivagen to expand domestic sterile injectable production in Sacramento, Calif.

"PAI is a market leader in RTU oral liquid medicines, and that same focus on quality, reliability, and patient-centric design carries naturally into RTU injectables," said Kurt Orlofski, CEO of PAI ...

New manufacturing workers can get acquainted with the equipment and procedures at Pfizer’s upcoming sterile injectables plant without ever setting foot inside. Armed with a virtual reality wearable ...

Over the past few years, drug shortages have become an ever-present challenge for hospital pharmacies, with shortages at their highest in over a decade1 and the majority of those, 53 percent, were for ...

Dublin, Dec. 16, 2019 (GLOBE NEWSWIRE) -- The "Sterile Injectable Drug Product Manufacturing Market Overview and Outlook" report has been added to ResearchAndMarkets.com's offering. Current demand for ...

WILMINGTON, DE & WHIPPANY, NJ — The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility ...

WILMINGTON, Del. & WHIPPANY, N.J.--(BUSINESS WIRE)--The Noramco Group, an integrated North American-based API and drug product supply chain product and services provider, today announced a $25 million ...

The generic sterile injectables market accounted for $ 68.7 billion in 2019 and is estimated to be $196.2 billion by 2029 and is anticipated to register a CAGR of 11.2%, per a report from Prophecy ...

WuXi STA launched a high potency, fully-automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new line has an annual capacity of 12 million units and meets ...

Five years after partnering up with Berkshire Sterile Manufacturing, Sharp Services is buying out the fill-finish CDMO for an undisclosed sum. Sharp, a 71-year-old subsidiary of Ireland-based UDG ...